en
Scientific article
Case report
Open access
English

Sporadic late onset nemaline myopathy with monoclonal gammopathy of undetermined significance: two cases with long term stability

Published inEuropean Journal of Translational Myology, vol. 30, no. 3, 9225
Publication date2020
Abstract

Monoclonal gammopathy of undetermined significance (MGUS) associated to sporadic late onset nemaline myopathy (SLONM) is a rare and severely disabling condition of quickly progressive limb girdle acquired myopathy. It is believed by some authors to be due to myotoxicity of light chain deposits. Two female patients were diagnosed with MGUS associated SLONM. In the first case, diagnosis was delayed by 6 years thus giving time for a severe generalized myopathy and cardiomyopathy to develop. A single anti-myeloma chemotherapy with lenalidomide markedly improved and stabilized the patient's condition despite respiratory and cardiac insufficiency. In our second patient the condition was identified one year after onset of the first symptom and markedly improved after autologous bone marrow transplantation and lenalidomide. Clinicians should be aware of monoclonal gammopathy associated sporadic late onset nemaline myopathy as this acquired muscle disorder, although extremely rare, may be reversed by adequate management.

Citation (ISO format)
TRUFFERT, André et al. Sporadic late onset nemaline myopathy with monoclonal gammopathy of undetermined significance: two cases with long term stability. In: European Journal of Translational Myology, 2020, vol. 30, n° 3, p. 9225. doi: 10.4081/ejtm.2020.9225
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2037-7452
182views
67downloads

Technical informations

Creation12/17/2020 5:20:00 PM
First validation12/17/2020 5:20:00 PM
Update time03/15/2023 11:44:41 PM
Status update03/15/2023 11:44:40 PM
Last indexation02/12/2024 1:22:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack